HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients.

Abstract
A retrospective comparative study was performed to determine the impact of infection control measures (ICMs) on colonization and infections due to methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae (producing transferable extended-spectrum beta-lactamase, KPESBL), and multi-resistant Enterobacter aerogenes (MREA) in intensive care unit patients. Infection Control Measures included surveillance cultures, isolation procedures and mupirocin for MRSA nasal carriage. The numbers of patients infected and/or colonized by MRSA, KPESBL or MREA were compared during two consecutive one-year periods (Period 1 before ICMs, and Period 2 after ICMs). The antibiotic consumption during the two periods was analysed. In Period 1 and Period 2, respectively, the rate of patients infected or colonized by at least one of the three organisms was 15% and 6.8% (P=0.001); by MRSA 7.7% and 2.6% (P=0. 004); by KPESBL 1.7% and 0% (P=0.25); and by MREA 5.6% and 4.3% (P=0. 47). During Period 2, there was a clear-cut decrease in the percentage of patients infected by MRSA (P=0.018), a non-significant decrease in those infected by KPESBL (P=0.06), and no decrease in patients infected by MREA (P=0.22). When calculated per 1000 patient-days, for Period 1 and Period 2, respectively, the rate of patients infected or colonized by at least one of the three organisms was 11.9 and 8.8; for MRSA it was 4 and 2.2; for KPESBL it was 1 and 0; and for MREA it was 4 and 4. Antibiotic cost was pound98.7 in Period 1 and pound62.7 in Period 2. ICMs contributed to the control of infections and colonizations due to MRSA and KPESBL but not those due to MREA.
AuthorsB Souweine, O Traore, B Aublet-Cuvelier, L Bret, J Sirot, H Laveran, P Deteix
JournalThe Journal of hospital infection (J Hosp Infect) Vol. 45 Issue 2 Pg. 107-16 (Jun 2000) ISSN: 0195-6701 [Print] England
PMID10860687 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2000 The Hospital Infection Society.
Chemical References
  • Anti-Bacterial Agents
Topics
  • Aged
  • Anti-Bacterial Agents (economics, therapeutic use)
  • Bacterial Infections (microbiology, prevention & control)
  • Drug Costs
  • Drug Resistance, Multiple
  • Enterobacteriaceae Infections (epidemiology, prevention & control)
  • Female
  • France (epidemiology)
  • Humans
  • Infection Control (methods)
  • Intensive Care Units
  • Klebsiella Infections (epidemiology, prevention & control)
  • Klebsiella pneumoniae
  • Male
  • Methicillin Resistance
  • Retrospective Studies
  • Staphylococcal Infections (epidemiology, prevention & control)
  • beta-Lactam Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: